Rituximab as possible first-line therapy for glomerulonephritis in HCV-related mixed cryoglobulinaemia [10]

Rheumatology

Volumn 45, Issue 6, 2006, Pages 784-785

  De Vita, Salvatore ^a   Quartuccio, Luca ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; PEGINTERFERON; RIBAVIRIN; RITUXIMAB; STEROID;

CLINICAL TRIAL; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG CHOICE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; GLOMERULONEPHRITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LETTER; LONG TERM CARE; MAINTENANCE THERAPY; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SHORT COURSE THERAPY; TREATMENT FAILURE;

EID: 33745633863     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel135     Document Type: Letter

References (10)

1. Quartuccio L, Soardo G, Romano G et al. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinemia: Efficacy and safety in the absence of steroids. Rheumatology 2006 [Epub ahead of print published on January 17, 2006. doi.10.1093/rheumatology/kel004].
2. Cacoub P, Saadoun D, Limal N, Sene D, Lidove O, Piette JC. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2005;52:911-5
3. Mazzaro C, Zorat F, Caizzi M et al. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: A pilot study. J Hepatol 2005;42:632-8.
4. Roccatello D, Baldovino S, Rossi D et al. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinemic glomerulonephritis. Nephrol Dial Transplant 2004;19:3054-61.
5. Zaja F, De Vita S, Mazzaro C et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 2003;101: 3827-34.
6. Basse G, Ribes D, Kamar N et al. Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients. Transplantation 2005;80:1560-4.
7. Bruchfeld A, Lindahl K, Stahle L, Soderberg M, Schvarcz R. Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. Nephrol Dial Transplant 2003;18:1573-80.
8. Tavoni A, Mosca M, Ferri C et al. Guidelines for the management of essential mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13:191-5.
9. Levine JW, Gota C, Fessler BJ et al. Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus. J Rheumatol 2005;32:1164-7.
10. Beuthien W, Mellinghoff HU, Kempis J. Vasculitis complications of interferon-alpha treatment for chronic hepatitis C virus infection: Case report and review of the literature. Clin Rheumatol 2005;24:507-15.